Compare Elder Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC PHARMA ELDER PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x -0.2 16.3 - View Chart
P/BV x 0.1 3.7 2.7% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 ELDER PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC PHARMA
Mar-19
ELDER PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs380664 57.2%   
Low Rs188412 45.6%   
Sales per share (Unadj.) Rs491.2208.7 235.3%  
Earnings per share (Unadj.) Rs-3.231.0 -10.3%  
Cash flow per share (Unadj.) Rs14.437.1 38.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs376.5144.2 261.1%  
Shares outstanding (eoy) m20.54188.52 10.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.6 22.4%   
Avg P/E ratio x-89.317.4 -514.1%  
P/CF ratio (eoy) x19.714.5 135.9%  
Price / Book Value ratio x0.83.7 20.2%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m5,833101,461 5.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1797,467 29.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,08939,347 25.6%  
Other income Rs m25794 273.6%   
Total revenues Rs m10,34639,441 26.2%   
Gross profit Rs m-7928,736 -9.1%  
Depreciation Rs m3611,152 31.4%   
Interest Rs m2,756184 1,497.2%   
Profit before tax Rs m-3,6537,493 -48.7%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,568 8.0%   
Profit after tax Rs m-655,844 -1.1%  
Gross profit margin %-7.822.2 -35.4%  
Effective tax rate %-3.420.9 -16.4%   
Net profit margin %-0.614.9 -4.4%  
BALANCE SHEET DATA
Current assets Rs m9,24019,577 47.2%   
Current liabilities Rs m9,99814,896 67.1%   
Net working cap to sales %-7.511.9 -63.1%  
Current ratio x0.91.3 70.3%  
Inventory Days Days4690 51.6%  
Debtors Days Days6045 132.2%  
Net fixed assets Rs m10,12427,097 37.4%   
Share capital Rs m206377 54.6%   
"Free" reserves Rs m5,58226,811 20.8%   
Net worth Rs m7,73427,188 28.4%   
Long term debt Rs m4,8894,993 97.9%   
Total assets Rs m22,88247,778 47.9%  
Interest coverage x-0.341.7 -0.8%   
Debt to equity ratio x0.60.2 344.2%  
Sales to assets ratio x0.40.8 53.5%   
Return on assets %11.812.6 93.2%  
Return on equity %-0.821.5 -3.9%  
Return on capital %22.323.6 94.5%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30719,453 1.6%   
Fx outflow Rs m1256,065 2.1%   
Net fx Rs m18113,388 1.4%   
CASH FLOW
From Operations Rs m11,7548,120 144.8%  
From Investments Rs m-561-7,556 7.4%  
From Financial Activity Rs m-6,762590 -1,145.3%  
Net Cashflow Rs m4,4321,153 384.3%  

Share Holding

Indian Promoters % 39.6 74.1 53.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 2.9 258.6%  
FIIs % 16.8 9.1 184.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 13.9 259.7%  
Shareholders   16,479 49,328 33.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   ALEMBIC LTD  SUN PHARMA  DISHMAN PHARMA  PFIZER  JUBILANT LIFE SCIENCES  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - ALEMBIC LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS